Is β-endorphin the same as morphine?

No, though they act on similar receptors. β-endorphin is a naturally produced peptide, while morphine is a plant-derived alkaloid. β-endorphin is actually more potent than morphine at opioid receptors.

How can I increase my β-endorphin levels naturally?

Exercise (especially prolonged aerobic exercise), meditation, laughter, music, social bonding, and certain foods can stimulate β-endorphin release. Acupuncture and massage may also have effects.

What is the runner's high?

The runner's high is a euphoric state experienced during prolonged exercise, attributed partly to β-endorphin release. Recent research also implicates endocannabinoids. It represents natural reward for beneficial physical activity.

Fact-checked by the Peptide Authority Editorial Board · Last reviewed: 1 February 2026

Share:X Post LinkedIn

Neuropeptides•Updated 2026-02-01•5 min read

What Is Beta-Endorphin? Benefits, Research & Safety

The body's natural opioid peptide involved in pain modulation, stress response, and reward, mediating the 'runner's high' and other euphoric states.

Share:X Post LinkedIn

Also known as:

β-Endorphin

Endorphin

AStrong human evidenceUK: Sold as 'research only' (UK)WADA: Sport status unclear

UK summary: Endogenous opioid peptide. Not a medicine (too short half-life and too central a target). Released in exercise, stress, and pain modulation — this entry is educational background.

Quick Facts

Overview

Beta-endorphin (β-endorphin) is a 31-amino acid endogenous opioid peptide derived from the proopiomelanocortin (POMC) precursor, the same precursor that produces ACTH and α-MSH. It is the most potent naturally occurring opioid in the human body. β-endorphin binds primarily to μ (mu) opioid receptors, which mediate analgesia, euphoria, and respiratory depression. It plays crucial roles in pain modulation, stress response, reward processing, and homeostatic regulation. The peptide is produced in the pituitary gland and hypothalamus, released in response to stress, pain, and exercise. It is famously associated with the "runner's high" and the euphoric feelings following intense physical activity. Beyond pain and pleasure, β-endorphin influences immune function, appetite, sexual behavior, and the body's response to stress. It is part of an integrated system linking the nervous, endocrine, and immune systems. β-endorphin is not used directly as a therapeutic agent, primarily due to its opioid effects and abuse potential. However, understanding endorphin biology informs approaches to pain management, addiction, and mood disorders.

Evidence standards summary

Beta-Endorphin — evidence and risk at a glance

Twenty standard modules scored against the Peptide Authority evidence grading methodology. Missing modules indicate the field has not yet been characterised editorially — treat absences as uncertainty rather than reassurance.

01Evidence snapshot

AStrong human evidenceOverall grade against our evidence grading methodology.

Endogenous opioid peptide. Not a medicine (too short half-life and too central a target). Released in exercise, stress, and pain modulation — this entry is educational background.

02Human evidence grade

AStrong human evidenceStrength of evidence from published human trials.

03Preclinical evidence grade

AStrong human evidenceAnimal-model and in-vitro evidence quality.

04Regulatory status

UK: Not a therapeutic agent. Research compound only.
EU: Not used therapeutically.
Notes: β-endorphin is studied as an endogenous substance but not used as a medication due to its opioid properties. Research focuses on understanding the endogenous system rather than administering the peptide.

05Approved medical uses

None in the UK or EU as a finished medicine. (Or: not yet documented; treat as absence rather than approval.)

06Unapproved / promotional claims

Endorphin supplements lift mood / reduce pain.
Buy endorphin peptides for natural pain relief.

07Common internet claims

Sold as 'endorphin supplements' in wellness retail.
Marketed as a natural mood-lifter peptide.

08Claim vs evidence

Claim	Evidence	Human evidence?	Regulatory concern	Safer wording
“Endorphin supplements lift mood”	E	No	High	Beta-endorphin cannot be taken orally; 'endorphin supplements' have no mechanism. Exercise reliably raises endogenous endorphin levels.

09Safety uncertainty score

Moderate

Safety profile partly characterised; some signals from observational or preclinical data.

10Known adverse signals

Oral endorphin products have no rational mechanism; safety depends on what's actually in the supplement.

11Drug-interaction uncertainty

Moderate

Some interaction data published; check with a prescriber for your specific medicines.

12Anti-doping status

WADA: Sport status unclearWADA strict-liability framing applies.

13UK legal position

UK: Sold as 'research only' (UK)

Not a therapeutic agent. Research compound only.

14EU legal position

Not used therapeutically.

15What this page cannot tell you

What 'endorphin supplements' actually contain.
Whether they produce any measurable effect on endogenous endorphin tone.

16Last reviewed

Last reviewed: 1 February 2026

Next review due: 1 February 2027

Spotted an error or something out of date? Send a correction.

17Citation quality score

AStrong human evidenceQuality of the sources we cite, graded against the evidence grading methodology.

18Research gaps

Exogenous endorphin pharmacology is not a viable therapeutic route due to BBB and half-life issues.

19Safer alternatives / established care pathways

Regular exercise — the most reliable evidence-based way to raise endogenous endorphin tone.
NHS Talking Therapies for mood concerns.
Pain-clinic referral for chronic pain via GP.

20Doctor discussion prompts

Questions to ask a qualified clinician

These are starter questions you can adapt for a GP, specialist, pharmacist, or anti-doping advisor. The aim is to help you have a better-informed conversation — not to replace one.

What evidence-based interventions affect endorphin / pain pathways for my situation?

Discovery & History

The search for endogenous opioids began after the discovery of opioid receptors in the 1970s. If receptors for morphine existed, researchers reasoned, the body must produce its own opioid-like substances. In 1975, John Hughes and Hans Kosterlitz discovered the enkephalins, the first identified endogenous opioids. Shortly after, β-endorphin was isolated from pituitary extracts and characterised as a potent opioid peptide. The discovery that β-endorphin derived from the same precursor (POMC) as ACTH established a direct link between stress hormone and opioid systems. This explained why stress could simultaneously activate cortisol release and pain modulation. Research in the 1980s and 1990s explored β-endorphin's roles beyond pain, including its effects on mood, reward, immunity, and behavior. The concept of "exercise-induced analgesia" and the runner's high became linked to endorphin release. The identification that acupuncture, massage, and other therapies could stimulate endorphin release provided mechanistic explanations for some traditional practices. Current research examines endorphin dysfunction in chronic pain conditions, depression, and addiction, seeking therapeutic approaches that enhance or modulate the endogenous opioid system.

Mechanism of Action

β-endorphin exerts its effects primarily through opioid receptor activation: **μ-Opioid Receptor (MOR) Activation** The primary target of β-endorphin: - Analgesia (pain relief) - Euphoria and pleasure - Respiratory depression (at high levels) - Decreased gastrointestinal motility - Physical dependence potential **δ and κ Opioid Receptors** Some activity at other opioid receptors: - δ receptors: Analgesia, mood effects - κ receptors: Dysphoria at higher activation **Pain Modulation** Central and peripheral effects on pain: - Inhibits pain signal transmission in spinal cord - Modulates pain perception in brain - Part of descending pain inhibition system - Works synergistically with other pain modulators **Stress Response Integration** Links stress and pain systems: - Released alongside ACTH in stress - Modulates HPA axis activity - May protect against stress-induced damage - Contributes to stress-induced analgesia **Reward and Motivation** Effects on reward circuitry: - Contributes to pleasure and reinforcement - Involved in food reward - Role in addiction neurobiology - Mediates natural rewards (exercise, social bonding)

Researched Benefits

Based on preclinical and clinical research findings:

1
Natural pain relief and analgesia
2
Stress reduction and anxiety relief
3
Mood elevation and euphoria
4
Immune system modulation
5
Regulation of reward and motivation
6
Mediates benefits of exercise, meditation, and other practices

Claim vs Evidence

How popular claims about Beta-Endorphin stack up against the current research, graded using our public evidence grading methodology.

Claim	Evidence	Human evidence?	Regulatory concern	Safer wording
“Endorphin supplements lift mood”	E	No	High	Beta-endorphin cannot be taken orally; 'endorphin supplements' have no mechanism. Exercise reliably raises endogenous endorphin levels.

Theoretical Dosing & Protocols

⚠️ Educational Only: The following information is derived from research literature and is not a prescription or recommendation. No standardised human dosing exists. Always consult a qualified healthcare professional.

Theoretical Dosage	Not administered therapeutically due to opioid effects
Frequency	N/A
Duration	N/A
Notes	β-endorphin is not used as a therapeutic agent due to its opioid activity and abuse potential. Research focuses on understanding endogenous endorphin systems and how to enhance natural endorphin release through exercise, meditation, and other means.

Administration Routes

Routes studied in research settings (educational only):

Not administered therapeutically
Research uses intracerebroventricular or intravenous routes in animal studies

Half-Life	Stability
Short in plasma; rapidly degraded by peptidases	Subject to enzymatic degradation; requires careful handling in research

Safety Profile & Known Risks

Commonly Reported Side Effects

Not administered therapeutically—effects relate to endogenous release

Rare Risks & Concerns

Exogenous administration would have opioid effects
Respiratory depression, sedation
Physical dependence potential

Contraindications

Exogenous β-endorphin administration is not a clinical practice

UK & EU Regulatory Context

🇬🇧 United Kingdom

Not a therapeutic agent. Research compound only.

🇪🇺 European Union

Not used therapeutically.

β-endorphin is studied as an endogenous substance but not used as a medication due to its opioid properties. Research focuses on understanding the endogenous system rather than administering the peptide.

Clinical Studies Summary

Neurophysiological Effects of Dry Needling: A Systematic Review and Meta-analysis.

The application of dry needling can induce significant changes in pain-related biomarker levels in animal and human studies, providing insights into its underlying mechanisms of action and potential clinical effects.

Arch Phys Med Rehabil. 2026View on PubMed

A Systematic Review With Meta-Analysis of Endogenous Opioid System Biomarkers in Patients With Chronic Axial Pain, Chronic Widespread Pain, and Fibromyalgia.

Current evidence does not support altered peripheral endorphin levels in FM or cLBP, while emerging PET findings indicate reduced central MOR availability in FM. These results suggest receptor-level dysregulation rather than peripheral opioid deficits.

Eur J Pain. 2026View on PubMed

Association of endogenous hormones with major depressive disorder phenotype: A systematic review and meta-analysis of drug-free case and control cross-sectional study.

This meta-analysis highlights alterations across the HPA/HPT/HPG axes in MDD patients. More studies focusing on these hormonal markers within specific MDD subtypes are warranted to clarify their mechanistic roles and provide stronger evidence of their association with this heterogeneous disorder.

Biochem Biophys Res Commun. 2025View on PubMed

Systematic review and exploratory meta-analysis of the efficacy, safety, and biological effects of psychostimulants and atomoxetine in patients with schizophrenia or schizoaffective disorder.

No efficacy for stimulants or atomoxetine on negative symptoms is proven. Atomoxetine or amphetamines may improve cognitive symptoms, while methylphenidate should be avoided in patients with schizophrenia. Insufficient evidence is available to draw firm conclusions.

CNS Spectr. 2019View on PubMed

Migraine biomarkers in cerebrospinal fluid: A systematic review and meta-analysis.

Conclusions Glutamate, β-EP, CGRP and NGF concentrations are altered in CSF and, except for NGF, also in blood of migraineurs. Future research should focus on the pathophysiological roles of these compounds in migraine.

Cephalalgia. 2017View on PubMed

Giant Basal Cell Carcinomas Express Neuroactive Mediators and Show a High Growth Rate: A Case-Control Study and Meta-Analysis of Etiopathogenic and Prognostic Factors.

GBCC etiopathogenesis is multifactorial (ie, tumor biology, psychosocial factors). BCC production of paracrine neuromediators deserves further study.

Am J Dermatopathol. 2017View on PubMed

Registered Trials & Regulatory Status

Registered trials

Currently recruiting

Furthest phase

Phase 4

Approved product

7 of 9 completed trials have never posted results. Unreported trials are not neutral: results that go unpublished are more often negative ones.

Effect of Endorphin Massage on Surgical Fear, Anxiety and Pain Before Mastectomy

Status: Not Yet Recruiting · 82 participants · Ataturk University

Conditions: Postoperative Pain, Anxiety, Fear

No results postedNCT06755983

Plasma Beta-endorphin Levels and Suicidal Behavior

Status: Unknown · 104 participants · University Hospital, Montpellier

Conditions: Suicide, Depression, Beta Endorphin

No results postedNCT06291467

Does Endorphin Massage Reduce the Anxiety of Pregnant Women?

Status: Unknown · 68 participants · Manisa Celal Bayar University

Conditions: Pregnancy Related

No results postedNCT06342154

The Effect of Endorphin Massage Applied to Postpartum Women on Anxiety and Fatigue Levels

Status: Completed · 50 participants · TC Erciyes University

Conditions: Birth, Anxiety, Fatigue

No results postedNCT06421233

Endorphin Massage Application to Women Who Gave Birth Vaginally

Status: Completed · 80 participants · TC Erciyes University

Conditions: Pain, Birth, First

No results postedNCT05764512

Endorphin at Labor Pain and Acupressure

Status: Completed · 140 participants · Serap ÖZTÜRK ALTINAYAK

Conditions: Labor Pain

No results postedNCT04367038

The Effect of Foot Reflexology on Pain, Comfort and Beta Endorphin Levels in Patients With Liver Transplantation

Status: Completed · 120 participants · Inonu University

Conditions: Liver Transplant; Complications

No results postedNCT04828356

Effects of Laughter Yoga on Hemodialysis Patients' Plasma-Beta Endorphin Levels, Pain Levels and Sleep Quality

Status: Completed · 68 participants · Istanbul Sabahattin Zaim University

Conditions: Laughter Yoga, Hemodialysis Patients

No results postedNCT04175652

Differentiating the Effects of Substance P and Beta-endorphin

Status: Completed · 10 participants · Dartmouth-Hitchcock Medical Center

Conditions: Chronic Obstructive Pulmonary Disease

Results postedNCT01854177

CGRP, Estrogen, Cortisol, VIP, α-Amylase, PGE2, PGI2 and ß-Endorphin Levels in Menstrual Migraine Before and After Treximet

PHASE4

Status: Completed · 41 participants · Cady, Roger, M.D.

Conditions: Menstrual Migraine

Results postedNCT01329562

Role of Beta-Endorphin in Cancer Therapy Fatigue

N/A

Status: Terminated · 18 participants · Massachusetts General Hospital

Conditions: Breast Cancer, Fatigue

No results postedNCT01113905

Acute Effects of Acu-Transcutaneous Electrical Nerve Stimulation (Acu-TENS) on Forced Expiratory Flow Volume in One Second (FEV1) and Blood β-Endorphin Level in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Status: Completed · 44 participants · The Hong Kong Polytechnic University

Conditions: Chronic Obstructive Pulmonary Disease (COPD)

No results postedNCT00922051

Adverse event reports (FDA FAERS)

Not applicable: no licensed product contains this peptide, so it is not reported through FAERS. This is an absence of surveillance, not evidence of safety.

Source: ClinicalTrials.gov and openFDA. Updated automatically.

Looking for Beta-Endorphin?

Source research-grade Beta-Endorphin from a trusted UK supplier — third-party tested with certificate of analysis.

View at Supplier

Frequently Asked Questions

Questions to ask a qualified clinician about Beta-Endorphin